Abstract
dc:descriptionAims and scope: This observational, retrospective study aims to assess structural changes in the gray matter (GM) and white matter (WM) among patients with Alzheimer’s disease (AD), Parkinson’s disease dementia (PDD), dementia with Lewy bodies (DLB) and corticobasal syndrome (CBS), via analysis of magnetic resonance imaging (MRI) of the brain. These neurodegenerative diseases share many common clinical features, presenting challenges for bedside diagnosis. Methods: Participants. All patients were recruited from the Neurology Department of the University Hospital of Ioannina. Their clinical evaluation was performed by two Neurologists (blinded). Inclusion criteria were age 50-80 years. Exclusion criteria included a history of major psychiatric or neurodevelopmental disorder, substance abuse, ischemic or hemorrhagic stroke, severe head trauma, intracranial surgery, tumor, arteriovenous malformation, or other intracranial mass, as well as a significant burden of white matter hyperintensities (Fazekas 2 or higher), or motion artefacts. All patients were thoroughly evaluated by two Neurologists (blinded). Patients were diagnosed according to the current clinical criteria for a probable diagnosis. Patients with either PDD or DLB were studied together, as a Lewy body dementias (LBD) group. For all subjects, relevant demographic data including age, gender, education level (years of education) and clinical indices such as disease duration were recorded for structural brain evaluation. These indices were used as covariates in the group comparisons conducted. Neuropsychological assessment. All patients and HC underwent an extensive neuropsychological assessment by a specialized speech therapist (blinded). The following neuropsychological batteries were administered: Addenbrooke’s Cognitive Examination-Revised (ACE-R), Frontal Assessment Battery, Verbal Fluency Task, Trail Making Test A and B, Neuropsychiatric Inventory, and Geriatric Depression Scale. Statistical analysis. Continuous demographic and clinical variables were assessed for normality using the Shapiro-Wilk test and subsequently analyzed with one-way ANOVA, followed by post-hoc comparisons to assess group differences between study groups. For nominal variables, the Pearson Chi-Square test and Fisher's Exact test were employed to determine significance. Imaging analysis. Imaging was performed using T2W, FLAIR, T1W high resolution and a diffusion tensor imaging sequence. Cortical surface analysis of the high-resolution T1-weighted structural images was followed by Tract-Based Spatial Statistics (TBSS) analysis of the diffusion images. Voxel-wise comparisons of cortical surface and diffusion metrics were conducted to assess differences among the groups. Results: Demographics and clinical data. The study included 12 AD patients, 15 LBD patients (either dementia with Lewy bodies or Parkinson’s disease dementia), 11 CBS patients, and 11 healthy controls (HC). No differences were found between groups for sex, disease duration, years of education or other socioeconomic factors. However, the AD group was younger (p < 0.05), compared to the LBD and CBS groups. Memory impairment was main clinical feature for the AD group, while gait impairment or other motor features were the main clinical features for the LBD and CBS groups. All groups had low mean ACE-R scores (< 82/100). AD scores were poorer for memory and language subtests. CBS groups had the poorer performance in language tests, especially phonemic fluency. Lastly, all three groups performed poorly at visuospatial tests. Cortical Surface. All patient groups exhibited atrophy compared to the healthy controls. AD showed cortical surface area (CSA) reduction in the frontal lobe (p=0.0002), especially in both left and right superior frontal cortices (SFC), along with reduction in the right orbitofrontal cortex (OFC), and right middle frontal cortex (p < 0.-05). Cortical volume (CV) reduction was also observed in the right SFC (p = 0.0002), right OFC (p = 0.0002), and right MFC, (p < 0.05). Additionally, LBD showed reduced CSA of the left superior temporal cortex (STC), while reduced CSA in another area of the STC was also shown in the CBS group (p < 0,05). No differences were detected between patient groups, except in the case where LBD demonstrated larger cortical thickness than AD in a region of the inferior parietal lobe. Diffusion Metrics. Widespread differences in diffusion metrics were detected in all major white matter tracts between individuals with AD and HC or those with LBD. In both cases, individuals with Alzheimer’s disease exhibited lower fractional anisotropy (FA) and axial diffusivity (AxialD), along with higher radial diffusivity (RD). Finally, patients with CBS presented larger RD than patients with LBD in a small region of the left cingulate gyrus. Conclusions: The results indicate significant structural changes in the GM of the frontal lobe in AD patients, an area not commonly associated with AD pathology, at least in the early stages of the disease. These changes suggest reduced structural integrity and disconnection of the underlying WM tracts in AD patients. Moreover, the significant WM alterations of the AD group are also suggestive of reduced structural integrity and increased water diffusivity within the white matter microstructure. The association of these findings with the course of AD remains undefined. One possible explanation is the so-called disconnection hypothesis, suggesting that AD symptomatology is not solely the result of the topographical distribution of accumulated amyloid plaques and neurofibrillary tangles, but rather a disorganized interaction between neuronal networks, leading to disturbed connectivity within the brain. Future studies focusing on network analysis of human brain connectivity are needed to test this hypothesis.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Giannakis, Alexandros
- Γιαννάκης, Αλέξανδρος
Subjects
dc:subject × 16- Νευροεκφυλιστικές νόσοι
- Νόσος Alzheimer
- Άνοια στη νόσο του Parkinson
- Φάσμα διαταραχών με σωμάτια Lewy
- Σύνδρομα Parkinson plus
- Neurodegenerative diseases
- Alzheimer's disease
- Parkinson's disease dementia
- Lewy bodies disorders spectrum
- Parkinson plus syndromes
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Κλινική νευρολογία
- Clinical Medicine
- Medical and Health Sciences
- Clinical Neurology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56550